✨ Medicines Classification




7 SEPTEMBER NEW ZEALAND GAZETTE 3003

Carbaryl; in medicines for external use, containing 2% or less of carbaryl

Cabenzolone; and its salts; compounds of carbenoxolone; in medicines for external use

Cardamom; compound tincture; aromatic tincture

Catechu

Cholecalciferol; in medicines containing 25 micrograms or less per recommended daily dose

Choline salicylate

Chlorhexidine

Chlorphenesin

Chymotrypsin

Cinchocaine; for external use in medicines containing 2% or less

Clioquinol; in medicines for external use

Contact lens solutions

Crocus sativus; extracts of

Crotamiton

2,4-Dichlorobenzyl alcohol

Dequalinium; and its salts

Dibromopropamidine isethionate; except for ophthalmological use

Diethylamine salicylate

Di-iodohydroxyquinoline; in medicines for external use

Dimenhydrinate; and its salts; in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Dioctyl sodium sulphosuccinate

Diphemanil; and its salts

Edetic acid; in medicines containing 0.25% or less

Ethyl nicotinate

Ethyl salicylate

Fenticlor; in medicines for external use

Fibrinolysin; in medicines for external use

Folic acid; in medicines containing 500 mcg or less per recommended daily dose

Galactose

Gentian compound concentrated infusion

Glycol salicylate

Guaiphenesin; in medicines containing 2% or less of guaiphenesin

8-Hydroxyquinoline; and its halogenated and alkyl derivatives and their salts; in medicines for external but not vaginal use

Haloprogin

Halquinol; in medicines for external use

Heparins; in medicines for external use

Hexetidine; in medicines for external but not vaginal use

Hexyl nicotinate

Histamine acid phosphate; in medicines containing 0.5% or less of histamine acid phosphate

Hyaluronidase; for external use

Hydroxocobalamin; in medicines containing 50 mcg or less of hydroxocobalamin per recommended daily dose

Intrinsic factor

Iodine; in medicines for external use

Iodoform

Lignocaine; and its salts; in medicines for external use containing 2% or less of lignocaine and in throat lozenges containing 30 milligrams or less per dose form

Malathion; in medicines for external use containing 2% or less of malathion

Meclozine; and its salts; in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Menthyl valerate

Methyl nicotinate

Nicotinamide; in medicines containing 100 mg or less per dose form

Nicotinic acid; in medicines containing 100 mg or less per dose form

Nicotinyl alcohol; in medicines containing 100 mg or less per dose form

Nonylic acid; and its derivatives

Oxymetazoline; and its salts; for nasal use when sold at an airport

Pancreatin

Paracetamol; in solid dose form for oral use, containing 500 mg or less of paracetamol and in packs containing not more than 10 grams of paracetamol per pack

Pepsin

Permethrin; in medicines containing 1% or less of permethrin

Phenothrin

Phenylephrine; and its salts; in eye preparations containing 0.12% or less of phenylephrine; and in nasal preparations when sold at an airport

Piperonyl butoxide

Polynoxylin

Potassium chloride; in medicines for oral rehydration therapy; for use in haemodialysis concentrates and peritoneal dialysis solutions

Potassium citrate; in medicines for oral rehydration therapy

Potassium guaiacolsulphonate

Pramocaine; for external use in medicines containing 2% or less

Prilocaine; for external use in medicines containing 2% or less

Promethazine theoclate; in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Pronase

Propyl undecylenate

Pumilio pine oil

Pyrethrins I and II

Quaternary ammonium antiseptic compounds

Quinine; and its salts; in medicines containing 50 mg or less of quinine per recommended daily dose

Salicylic acid; and its salts; in medicines for external use containing 12.5% or less of salicylic acid

Senega

Sodium bitartrate

Sodium dichloroisocyanurate

Sodium lauryl sulphoacetate

Sodium sulphide

Strontium chloride

Subtilisin A



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1995, No 96


NZLII PDF NZ Gazette 1995, No 96





✨ LLM interpretation of page content

πŸ₯ Classification of Medicines under the Medicines Act 1981 (continued from previous page)

πŸ₯ Health & Social Welfare
Medicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines, General Sale Medicines, Classification